Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer’s Disease on April 12, 2024
-
Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023
-
A. Duie Pyle Achieves Historic 100-Year Milestone
-
Watsco Boosts Annual Dividend 10% to $10.80 Per Share
-
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
-
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
-
Fuse to Showcase Solutions for Networking the Battlespace at Sea-Air-Space 2024
-
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024
-
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
-
Gilat Awarded Over $13M in Additional Orders from Satellite Operators for its World Leading SkyEdge IV and SkyEdge II-c Platforms
-
20 EH/s expansion fully funded
-
DIGA Labs Announces Strategic Partnership with Ambrus Studio, Unveiling New Horizons for Web3 Gaming Communities
-
Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
-
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
-
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
-
Microbix Announces Annual and Special Meeting Voting Results
-
Sachem Capital Reports Full Year 2023 Results
-
Edible Garden Reports 21.6% Year-over-Year Revenue Growth for 2023
-
Bitfarms Announces March 2024 Production and Operations Update
-
Digihost Announces 60% Month-Over-Month Increase in Cash and Crypto Position and Provides March 2024 Production Update
-
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
-
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
-
Enthusiast Gaming Advances Strategic Objectives with C$4.1 Million Sale of Select Non-Core Assets
-
Telesat and Government of Canada Agree to Terms on C$2.14 Billion Loan in Support of Telesat Lightspeed
-
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
-
Institutional Investors Express Support For Trian’s Candidates at Disney
-
Autolus Therapeutics Announces Changes to its Board of Directors
-
The Scotts Miracle-Gro Foundation and Doodles and Digits Partner to Bring "How It's Math" to Public Television
-
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Oatly to Report First Quarter 2024 Financial Results on April 30, 2024
-
Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
-
The Scotts Miracle-Gro Foundation and Doodles and Digits Partner to Bring "How It's Math" to Public Television
-
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
-
Sachem Capital Corp. Announces Dividend of $0.11 Per Share
-
Old National Announces Completion of Merger with CapStar
-
Enservco Corporation Reports 2023 Fourth Quarter and Full Year Financial Results
-
Brown & Brown, Inc. announces 2024 first-quarter earnings release and conference call dates
-
Brown & Brown, Inc. announces 2024 first-quarter earnings release and conference call dates
-
Radisson Announces Re-Appointment of Denis V Lachance as Interim President & Chief Executive
-
Nxu, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
-
Radisson Announces Re-Appointment of Denis V Lachance as Interim President & Chief Executive
-
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
-
Mawson Infrastructure Group Inc. Reports Q4 and Fiscal Year 2023 Financial Results
-
H World Group Limited Announces Put Right Notification for 3.00% Convertible Senior Notes due 2026
-
Aurora Mobile Partners with Moonshot AI to Provide Messaging Services and Verification Services for Kimi App
-
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
-
Global Net Lease, Inc. Announces Common Stock Dividend for the Second Quarter 2024
-
Townsquare Announces Repurchase of Just Under 10% of Outstanding Shares Reaffirms Q1’24 and FY’24 Guidance
